P

Inventor

EL-ARABY MOUSTAFA E

SA32 patents
⚠️ This page may combine multiple inventors who share the name “EL-ARABY MOUSTAFA E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV KING ABDULAZIZ

25 patents
US10836736B1Nov 17, 2020

Pharmaceutical composition with cytotoxic activity on colorectal cancer cells

UNIV KING ABDULAZIZ7 citations80
US11325885B2May 10, 2022

Method for treating stomach cancer

UNIV KING ABDULAZIZ1 citations72
US11312680B2Apr 26, 2022

Method for treating a patient having a colon cancer

UNIV KING ABDULAZIZ1 citations72
US11214537B2Jan 4, 2022

Method for making anti-cancer compounds

UNIV KING ABDULAZIZ1 citations72
US11142493B1Oct 12, 2021

Pharmaceutical composition for treating cancer

UNIV KING ABDULAZIZ1 citations72
US11136288B2Oct 5, 2021

Method for treating a patient having cancer

UNIV KING ABDULAZIZ1 citations72
US10988439B2Apr 27, 2021

Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancer

UNIV KING ABDULAZIZ1 citations72
US11220485B2Jan 11, 2022

Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereof

UNIV KING ABDULAZIZ1 citations70
US11180458B2Nov 23, 2021

Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancer

UNIV KING ABDULAZIZ1 citations70
US10844022B1Nov 24, 2020

Pharmaceutical composition and method of treating cancer

UNIV KING ABDULAZIZ1 citations70
US10882852B1Jan 5, 2021

3-vinylquinolines as cancer cells inhibitors

UNIV KING ABDULAZIZ1 citations67
US11312694B2Apr 26, 2022

Method for making propenamide compound

UNIV KING ABDULAZIZ0 citations59
US11214556B1Jan 4, 2022

Method of treating colorectal cancer

UNIV KING ABDULAZIZ0 citations59
US11174233B1Nov 16, 2021

Anti-cancer compounds having oxazolone derivation

UNIV KING ABDULAZIZ0 citations59
US11155528B2Oct 26, 2021

Bis-propenamide compounds and methods of treating cancer

UNIV KING ABDULAZIZ0 citations59
US11458144B1Oct 4, 2022

Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling

UNIV KING ABDULAZIZ0 citations56
US11345692B1May 31, 2022

3-vinylquinolines as cancer cells inhibitors

UNIV KING ABDULAZIZ0 citations56
US10888566B1Jan 12, 2021

Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compounds

UNIV KING ABDULAZIZ0 citations53
US10959987B2Mar 30, 2021

Imidazole-based compounds as hepatitis C virus inhibitors

UNIV KING ABDULAZIZ1 citations52
US10821096B1Nov 3, 2020

Compounds for inhibiting NS3 and compositions containing the inhibited protein

UNIV KING ABDULAZIZ1 citations52
US10844007B1Nov 24, 2020

Amide group-containing compounds and use for cancer treatment

UNIV KING ABDULAZIZ0 citations51
US10894794B1Jan 19, 2021

Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics

UNIV KING ABDULAZIZ0 citations46
US10683267B1Jun 16, 2020

Antidiabetic compounds

UNIV KING ABDULAZIZ0 citations46
US10654800B1May 19, 2020

Antidiabetic compounds

UNIV KING ABDULAZIZ0 citations46
US10842795B1Nov 24, 2020

Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compounds

UNIV KING ABDULAZIZ0 citations43

UNIV NEW YORK STATE RES FOUND

2 patents

HANGAUER JR DAVID G

1 patent

UNIV OF JEDDAH

1 patent

UNIV KING SAUD

1 patent

BARADWAN MOHAMMED A

1 patent

ALREEMI ROAA M

1 patent